Nervonik
Latest round
- Series B
Last raised
- Apr 2026
Total raised
- $66M
Investors
- 8
About Nervonik
Nervonik, Inc. develops advanced neuromodulation implants aimed at providing innovative therapeutic solutions for chronic neuropathic pain through electrical stimulation, enhancing patient quality of life. Nervonik, Inc. focuses on developing neuromodulation devices that address chronic neuropathic pain. The company founded by Aydin Babakhani (CEO) and is based in Los Angeles, US. In April 2026, Nervonik, Inc. Nervonik specializes in the development of innovative neuromodulation implants designed to provide therapeutic solutions for chronic neuropathic pain. Their core product offerings include miniaturized, power-efficient neuromodulation devices that target the peripheral nervous system (PNS) to modulate nerve activity through electrical stimulation. These implants are intended to disrupt pain signals before they reach the brain, providing a narcotic-free alternative for pain management. Currently available for research purposes, Nervonik's implants are particularly beneficial for patients suffering from intractable discomfort due to conditions such as neuropathy. The company primarily serves medical professionals and researchers in North America and Europe, with a focus on improving patient quality of life through advanced technology in pain management. The revenue model for Nervonik is based on direct sales of their neuromodulation devices to medical institutions and research facilities, as well as potential partnerships with healthcare providers for broader distribution. Transactions typically involve the procurement of their flagship neuromodulation implants, which are supplied alongside a wearable wireless power transfer device that enhances functionality and comfort. These products are expected to be offered under a structured pricing plan that may include bulk purchasing options for hospitals and clinics. Additionally, the company may engage in subscription models for ongoing access to software updates and enhancements via the associated digital application, facilitating data sharing between patients and healthcare professionals.
Who invested in Nervonik
8 investors across 2 rounds
See all investors in Nervonik
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nervonik
Who invested in Nervonik?
Nervonik has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nervonik raised?
Nervonik has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nervonik last raise money?
Nervonik's most recent round on record is a Series B, in Apr 2026.
What does Nervonik do?
Nervonik is a medical devices & equipment company.
Where is Nervonik headquartered?
Nervonik is headquartered in Los Angeles, US.
Which VCs invest in companies like Nervonik?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Nervonik's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Nervonik? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.